Guidant Recall |
Guidant & The FDA Have Issued A Defibrillator Recall | Guidant News |
|---|---|---|
Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of a malfunctioning Guidant Defibrillators & Pacemakers. If you or a loved one have suffered as a result of a defective Guidant Defibrillator or Guidant Pacemaker you may be entitled to compensation. For More Information about the Guidant Recall or for information about a Guidant Lawsuit Click here to contact one of our Guidant Attorneys today.
|
On June 17, 2005, Guidant Corporation issued a defibrillator recall for cardiac defibrillators implanted in 50,000 patients around the world due to potentially fatal malfunctions of the devices. There are approximately 38,000 patients in the United States with Guidant brand defibrillators, which reports indicate have failed 45 times and are responsible for at least two deaths since May 30th. The Guidant recall was issued for the following models of cardiac defibrillators and pacemakers:
* VIRTUS PLUS II and INTELIS II models available only outside the U.S. The Guidant Defibrillator Recall The Food and Drug Administration released a statement stating that they did not require Guidant to recall its products, but that they nevertheless supported the decision to address such serious allegations. The fact that this issue was finally addressed is of small comfort to the 50,000 people who continue to live in constant fear that their life-saving medical equipment may fail them when they need it the most. Guidant Corp knew that there were problems in its Prizm 2 DR model and continued to market it, but demanded a total redesign of the unit. The company knew the model had failed a small number of times before 2002, but claimed that future revisions would make it safer. Doctors then discovered that Contak Renewal defibrillators built before August 26th, 2004 demonstrated a large risk of shorting out and failing to function properly. Only when presented with two such problems did Guidant act in the best interest of the public and offer to recall and service their defective products. |
02/04/2008 - Boston Scientific Corp., the world's second-largest maker of heart devices, posted a loss on costs for legal expenses and job cuts. Sales rose more than analysts' estimated, boosting the shares in extended trading. More>>> 02/04/2008 - Medical device maker Boston Scientific Corp posted a fourth-quarter net loss on Monday as it took charges for restructuring operations, divesting assets and patent litigation. The company, which has focused on reducing costs and shedding non-core assets as it copes with downturns in its two key heart device markets, said the net loss was $458 million, or 31 cents a share. More>>> 11/19/2007 - Boston Scientific (NYSE:BSX) Corp. Monday said it reached an amended agreement to settle for $240 million claims related to product communications issued by Guidant Corp. in 2005 and 2006. More>>> 11/19/2007 - Boston Scientific is agreeing to pay another $45 million as part of a major settlement with thousands of heart patients over potentially faulty defibrillators. More>>>
|
Washington DC Office |
||
| Free Case Evaluation. Nationwide: 1-800-856-6405 | ||